CuraServe™ is a complete healthcare ecosystem that improves drug adherence and brings game-changing benefits to patients and healthcare providers. We use a series of outreach tools and messages, supported by predictive modeling and behavioural analytics, to increase the rate of drug adherence. As our CuraServe™ solution helps patients, it’s also generating a vast amount of patient data. That data is then anonymised and made available through CuraData™. The only way that pharmaceutical companies, academics and researchers can access this data by purchasing CuraTokens™. Curaizon™ is unique because our CuraServe™ solution generates the information that drives the value of our CuraData™ platform. We’re not simply offering another way of storing, sharing or mining data. Our data is the first-of-its-kind insight into real-time patient behaviour and adherence. Through our collaborations with research institutions, national health services and biotech companies, we shall create one of the most powerful and valuable data sources in healthcare. Our data and analytics will finally give the health and pharmaceutical industries the tools they have been looking for to bring about the change patients need. Leveraging our contracts with healthcare providers, we can quickly build an ecosystem of mutually beneficial stakeholders within the value chain.
CuraServe™ Development Begins.
CuraServe™ Testing Underway.
CuraServe™ Alpha Release Complete.
Token Presale Begins.
Token Public Sale Begins.
CuraData™ Beta Release Complete.
CuraServe™ Public Release.
CuraData™ Platform Growth.
Curadata™ 2.0 Release.
from 06/01/18 to 06/08/18
from 06/08/18 to 10/31/18
Hard Cap: 25,000,000 USD
Token Symbol: ctkn
Total Supply of Tokens: 500,000,000
Tokens Available for Sale: 250,000,000 CTKN (50%)
Can’t participate: United States (Total Restriction)
Registered Company: United Kingdom